Tirzepatide

Tirzepatide Injection 

• Tirzepatide injection is a prescription medicine that activates GIP and GLP-1 receptors.
• It is used for type 2 diabetes and, in approved formulations, chronic weight management.
• It is usually given as a subcutaneous injection once weekly.
• It helps lower blood glucose, reduce appetite, and slow stomach emptying.
• Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort.
• The dose is gradually increased according to the prescribing instructions to improve tolerability.
• It should be used only under medical supervision.